|
KMID : 0948920180170020107
|
|
Clinical Pain
2018 Volume.17 No. 2 p.107 ~ p.110
|
|
|
The Effect of Cervical Stellate Ganglion Block Using Botulinum Toxin Type A in Intractable Cancer-related Pain
|
|
Sohn Dong-Gyun
Park Geun-Young
Im Sun
Jeon Sang-Hoon
Choi Yong-Min
|
|
|
Abstract
|
|
|
Objective: For patients who do not relieve with pharmacological intervention, interventional treatment including neurolytic blocks may have a specific role in palliative cancer management.
Method: We performed cervical stellate ganglion block for the second time with Botulinum toxin type A mixed with 4 ml of normal saline, total 75 IU of Botulinum toxin type A, minimal effective dosage was measured to minimize the possible side effects.
Results: About 3 days later, the patient reported that her continuous pain intensity had decreased from 8/10 to 4/10 on the visual analogue scale score. The frequency of the pain attack that required additional morphine injections was also decreased. As a result, her maximum morphine requirement dose per day was significantly reduced.
Conclusion: In this case, cervical stellate ganglion block with Botulinum toxin had longer lasting effect in the continuous pain intensity and resulted in less frequent pain attack. Botulinum toxin can be a possible intervention material in intractable neuropathic pain related to cancer.
|
|
|
KEYWORD
|
|
|
Cancer pain, Botulinum toxin, Cervical stellate ganglionic block
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|